Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA rejects Titan drug for opioid dependence
Reuters
Wednesday, May 1, 2013 - 9:49am
tags:
FDA, Titan Pharmaceuticals, opioid addiction, Probuphine
Pfizer Reviewing Idea of Potential Split, CFO Says
Bloomberg
Wednesday, May 1, 2013 - 9:46am
tags:
Pfizer
Strong Botox sales boost Allergan profit
Reuters
Wednesday, May 1, 2013 - 9:44am
tags:
Allergan, Botox, earnings
Teva confirms over-the-counter availability of Plan B
The Fly on the Wall
Wednesday, May 1, 2013 - 9:42am
tags:
Plan B contraceptive, contraceptives, Teva, morning-after pill
A Drug-By-Drug Analysis Of Merck's Big Earnings Miss
Forbes
Wednesday, May 1, 2013 - 9:40am
tags:
Merck, earnings
Drugmakers Get Reprieve From Medicare Cost-Cutting Board
Bloomberg
Wednesday, May 1, 2013 - 9:36am
tags:
Medicare
Is All Well With These 4 Pharmaceutical Powerhouses?
Motley Fool
Wednesday, May 1, 2013 - 9:32am
tags:
Merck, Pfizer, GSK, Eli Lilly
Vertex posts loss, raises cystic fibrosis sales view
Reuters
Wednesday, May 1, 2013 - 9:09am
tags:
Vertex Pharmaceuticals, earnings
Raptor's FDA Approval Is New Test For Orphan Drug Pricing
TheStreet.com
Wednesday, May 1, 2013 - 9:09am
tags:
FDA, Raptor Pharmaceuticals, orphan drugs, procysbi, nephropathic cystinosis
Merck first-quarter sales disappoint
Yahoo/Reuters
Wednesday, May 1, 2013 - 9:06am
tags:
Merck, earnings
Novo Nordisk First-Quarter Profit Climbs on Insulins, Victoza
Bloomberg
Wednesday, May 1, 2013 - 9:04am
tags:
Novo Nordisk, earnings
Cytokinetics: A New Approach to Treating a Broken Heart
Motley Fool
Tuesday, April 30, 2013 - 10:54am
tags:
congestive heart failure, Cytokinetics, Omecamtiv Mecarbil, Amgen
Merck’s HPV Vaccine May Protect Girls With Fewer Doses
Bloomberg
Tuesday, April 30, 2013 - 10:32am
tags:
Merck, vaccines, HPV, Gardasil
Pfizer to seek re-examination of Xeljanz following negative opinion
Yahoo/Fly on the Wall
Tuesday, April 30, 2013 - 10:31am
tags:
Pfizer, Xeljanz
SEC Probes Former Dendreon CEO Stock Sales
Pharmalot
Tuesday, April 30, 2013 - 9:50am
tags:
SEC, Dendreon, Mitchell Gold
On verge of $13B merger, Valeant and Actavis stop talking
Fierce Pharma
Tuesday, April 30, 2013 - 9:47am
tags:
M&A, Valeant Pharmaceuticals, Actavis
Aveo Kidney Cancer Drug May Need More Study, FDA Says
Bloomberg
Tuesday, April 30, 2013 - 9:46am
tags:
kidney cancer, FDA, Aveo Pharmaceuticals, tivozanib
3 Biotech Companies Ripe for a Takeover
Motley Fool
Tuesday, April 30, 2013 - 9:00am
tags:
M&A, biotech, Regeneron, Bayer, Arena Pharmaceuticals, GSK, Theravance
OncoGenex initiates clincal trial of OGX-427
The Fly on the Wall
Tuesday, April 30, 2013 - 8:58am
tags:
OGX-427, OncoGenex, bladder cancer
FDA panel says Allergan's Juvederm data supports product effectiveness
Yahoo/Fly on the Wall
Tuesday, April 30, 2013 - 8:53am
tags:
FDA, Allergan, Juvederm, advisory panels, facial fillers

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.